Skip to main content
Premium Trial:

Request an Annual Quote

Lesson One: How to Stay on Scientists' Good Side

In his Tree of Life blog, Jonathan Eisen posts on PRISM, or the Partnership for Research Integrity in Science and Medicine. It's a coalition launched by the Association of American Publishers with the goal of convincing the scientific community that it's open-access journals, not subscription-based journals, that you should be worrying about. (Open access, it seems, undermines the peer review process.) Eisen writes of the program, "It is the last gasp of a dying breed -- publishers who refuse to do what is the right thing for science and society."


The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.